IL1B and Huntington disease: Interestingly, the tests based on the cell death kinetics have slightly better positive and negative predictive values (Appendix Table S2) than the tests based on IL‐1β, suggesting that pyroptosis monitoring better discriminates FMF patients from HD (Appendix Fig S10F–G) and from patients with other inflammatory conditions (Fig 6H and I) than quantifying IL‐1β release does.